Histogen to Present at the HC Wainwright 22nd Annual Global Investment Conference

Rhea-AI Summary

Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company, announced its participation in the HC Wainwright 22nd Annual Global Investment Conference. Richard W. Pascoe, the company's President and CEO, will present on September 15, 2020, at 11:30 a.m. Eastern Time. The presentation will be available via a live webcast, with a replay accessible for 90 days following the event on Histogen's Investors page. Histogen focuses on restorative therapeutics that promote natural biological repair, utilizing innovative technologies for various therapeutic applications.

SAN DIEGO, Sept. 01, 2020 (GLOBE NEWSWIRE) -- Histogen Inc. (NASDAQ: HSTO), a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function, today announced that Richard W. Pascoe, President and Chief Executive Officer of Histogen, will present at the HC Wainwright 22nd Annual Global Investment Conference.  The virtual presentation is scheduled for Tuesday, September 15, 2020 at 11:30 a.m. Eastern Time.

Presentation Details

Date: Tuesday September 15, 2020
Time: 11:30 a.m. Eastern Time (8:30 a.m. Pacific Time)
Live Webcast Link: https://wsw.com/webcast/hcw7/hsto/1625710

For those not available to listen to the live broadcast, a replay will be archived for 90 days and available through the Investors page on www.histogen.com.

About Histogen Inc.

Histogen Inc. is a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the body’s natural process to repair and maintain healthy biological function. Histogen’s innovative technology platform utilizes cell conditioned media and extracellular matrix materials produced by hypoxia-induced multipotent cells. Histogen’s proprietary, reproducible manufacturing process provides targeted solutions across a broad range of therapeutic indications including hair growth, dermal rejuvenation, joint cartilage regeneration and spinal disk repair. For more information, please visit www.histogen.com.

CONTACT:

Susan A. Knudson
Executive Vice President & CFO
Histogen Inc.
ir@histogen.com

FAQ

When will Histogen Inc. present at the HC Wainwright Conference?

Histogen Inc. will present on September 15, 2020, at 11:30 a.m. Eastern Time.

Who is presenting for Histogen Inc. at the conference?

Richard W. Pascoe, the President and CEO of Histogen Inc., will be presenting.

How can I access the live webcast of Histogen's presentation?

You can access the live webcast of Histogen's presentation at the following link: https://wsw.com/webcast/hcw7/hsto/1625710.

Will there be a replay of the Histogen Inc. presentation available?

Yes, a replay of the presentation will be archived for 90 days on Histogen's Investors page.

What is the focus of Histogen Inc.'s therapeutics?

Histogen Inc. focuses on developing restorative therapeutics that support the body's natural repair processes.